Curr Rheumatol Rep. 2008 Dec;10(6):442-8.

Vasculitis induced by tumor necrosis factor-targeted therapies.

Ramos-Casals M, Brito-Zerón P, Cuadrado MJ, Khamashta MA.

Source

Servei de Malalties Autoimmunes, Hospital Clínic, C/Villarroel, 170, 08036-Barcelona, Spain. mramos@clinic.ub.es

Abstract

Tumor necrosis factor (TNF)-targeted therapies are increasingly used for a rapidly expanding number of rheumatic and autoimmune diseases. With this use and longer follow-up periods of treatment, there are a growing number of reports of the development of autoimmune processes related to these new therapeutic agents. We have analyzed the clinical characteristics, outcomes, and patterns of association with the different anti-TNF agents used in all reports of vasculitis developed after TNF-targeted therapy. A total of 132 cases, identified up to July 2008, are included and analyzed in this review.

PMID:: 19007533; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Vasculitis - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. [Medicine (Baltimore). 2007]
Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.
Ramos-Casals M, Brito-Zerón P, Muñoz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA. Medicine (Baltimore). 2007 Jul; 86(4):242-51.
Review Autoimmune diseases induced by TNF-targeted therapies. [Best Pract Res Clin Rheumatol....]
Review Autoimmune diseases induced by TNF-targeted therapies.
Ramos-Casals M, Brito-Zerón P, Soto MJ, Cuadrado MJ, Khamashta MA. Best Pract Res Clin Rheumatol. 2008 Oct; 22(5):847-61.
Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series. [J Rheumatol. 2003]
Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series.
Jarrett SJ, Cunnane G, Conaghan PG, Bingham SJ, Buch MH, Quinn MA, Emery P. J Rheumatol. 2003 Oct; 30(10):2287-91.
Autoimmune bullous skin diseases occurring under anti-tumor necrosis factor therapy: two case reports. [Dermatology. 2010]
Autoimmune bullous skin diseases occurring under anti-tumor necrosis factor therapy: two case reports.
Boussemart L, Jacobelli S, Batteux F, Goulvestre C, Grange P, Carlotti A, Morini JP, Gorin I, Ziza JM, Avril MF, et al. Dermatology. 2010; 221(3):201-5.
Review mAbs in nonlupus autoimmune rheumatic disease. [Curr Opin Hematol. 2009]
Review mAbs in nonlupus autoimmune rheumatic disease.
Whelan BR, Isenberg DA. Curr Opin Hematol. 2009 Jul; 16(4):280-4.

See reviews... See all...

Cited by 1 PubMed Central article

Henoch-Schönlein purpura complicating adalimumab therapy for Crohn's disease. [World J Gastrointest Pharmacol...]
Henoch-Schönlein purpura complicating adalimumab therapy for Crohn's disease.
Rahman FZ, Takhar GK, Roy O, Shepherd A, Bloom SL, McCartney SA. World J Gastrointest Pharmacol Ther. 2010 Oct 6; 1(5):119-22.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Vasculitis induced by tumor necrosis factor-targeted therapies.
Vasculitis induced by tumor necrosis factor-targeted therapies.
Curr Rheumatol Rep. 2008 Dec ;10(6):442-8.

PubMed
A case report: using SNOMED CT for grouping Adverse Drug Reactions Terms.
A case report: using SNOMED CT for grouping Adverse Drug Reactions Terms.
BMC Med Inform Decis Mak. 2008 Oct 27 ;8 Suppl 1:S4.

PubMed
The UPS: a promising target for breast cancer treatment.
The UPS: a promising target for breast cancer treatment.
BMC Biochem. 2008 Oct 21 ;9 Suppl 1:S2.

PubMed
Abatacept in the treatment of rheumatoid arthritis.
Abatacept in the treatment of rheumatoid arthritis.
Arthritis Res Ther. 2008 ;10 Suppl 1:S5. Epub 2008 Oct 15 .

PubMed
Management of decreased bone mineral density in men starting androgen-deprivatio...
Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer.
BJU Int. 2009 Mar ;103(6):753-7. Epub 2008 Oct 24 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: